AstraZeneca antibody drug effective against BA.2, study finds

AstraZeneca antibody drug effective against BA.2, study finds

Source: 
Beckers Hospital Review
snippet: 

AstraZeneca's COVID-19 antibody drug Evusheld maintained effectiveness against various omicron subvariants, including BA.2, in a recent independent laboratory study, the drugmaker said March 21.